63539-236-14 |
63539-236 |
HUMAN PRESCRIPTION DRUG |
CIBINQO |
abrocitinib |
TABLET, FILM COATED |
ORAL |
20220224 |
N/A |
NDA |
NDA213871 |
U.S. Pharmaceuticals |
ABROCITINIB |
50 mg/1 |
14 TABLET, FILM COATED in 1 BOTTLE (63539-236-14) |
63539-336-14 |
63539-336 |
HUMAN PRESCRIPTION DRUG |
CIBINQO |
abrocitinib |
TABLET, FILM COATED |
ORAL |
20220224 |
N/A |
NDA |
NDA213871 |
U.S. Pharmaceuticals |
ABROCITINIB |
100 mg/1 |
14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14) |
0069-0235-30 |
0069-0235 |
HUMAN PRESCRIPTION DRUG |
Cibinqo |
abrocitinib |
TABLET, FILM COATED |
ORAL |
20220224 |
N/A |
NDA |
NDA213871 |
Pfizer Laboratories Div Pfizer Inc |
ABROCITINIB |
50 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (0069-0235-30) |
63539-436-14 |
63539-436 |
HUMAN PRESCRIPTION DRUG |
CIBINQO |
abrocitinib |
TABLET, FILM COATED |
ORAL |
20220224 |
N/A |
NDA |
NDA213871 |
U.S. Pharmaceuticals |
ABROCITINIB |
200 mg/1 |
14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14) |
0069-0435-30 |
0069-0435 |
HUMAN PRESCRIPTION DRUG |
Cibinqo |
abrocitinib |
TABLET, FILM COATED |
ORAL |
20220224 |
N/A |
NDA |
NDA213871 |
Pfizer Laboratories Div Pfizer Inc |
ABROCITINIB |
200 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (0069-0435-30) |
0069-0335-30 |
0069-0335 |
HUMAN PRESCRIPTION DRUG |
Cibinqo |
abrocitinib |
TABLET, FILM COATED |
ORAL |
20220224 |
N/A |
NDA |
NDA213871 |
Pfizer Laboratories Div Pfizer Inc |
ABROCITINIB |
100 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (0069-0335-30) |